Softens and minimizes the appearance of red or pink scars.
Appropriate for all skin types.
A synergistic complex comprising Centella asiatica, Bulbine frutescens and Oleuropein that helps minimize the appearance of scars.
Water/Aqua/Eau, Poloxamer 407, Bulbine Frutescens Gel, PEG-40, Hydrogenated Castor Oil, Propylene Glycol, Dimethicone, Olea Europaea Leaf Extract, Centella Asiatica Extract, Xanthan Gum, Lactic Acid, Potassium Sorbate, Sodium Benzoate, Phenoxyethanol
CAUTION: GlyPro products used together may cause irritation.
Sunburn alert: AHA/BHA Exfoliating Cleanser, AHA/BHA Cream, and all GlyPro products contain an alpha-hydroxy acid (AHA) that may increase your skin’s sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using these products, and for a week following discontinuation.
IMPORTANT! SUNSCREEN IS REQUIRED TO OPTIMIZE AND MAINTAIN THE RESULTS OF USING LYTERA® 2.0 PIGMENT CORRECTING SERUM.
Most SkinMedica® products are intended to meet the FDA’s definition of a cosmetic product, an article applied to the human body to cleanse, beautify, promote attractiveness, and alter appearances. These SkinMedica® products are not intended to be drug products that diagnose, treat, cure, or prevent any disease or condition. These products have not been approved by the FDA, and the statements have not been evaluated by the FDA.
SkinMedica® TOTAL DEFENSE + REPAIR Broad Spectrum Sunscreens (SPF 34, SPF 34 Tinted, and SPF 50+) and Essential Defense Broad Spectrum Sunscreens (Everyday Clear SPF 47, Mineral Shield Tinted SPF 32, and Mineral Shield SPF 35) are over-the-counter drug products that are formulated and marketed pursuant to the FDA’s governing regulations set forth at 21 CFR Part 352.
The PA rating system is used in Japan to classify UVA protection and is not an FDA requirement on sunscreens sold in the U.S.
SkinMedica® Acne System, Acne Treatment Lotion, Purifying Foaming Wash, and Purifying Toner are over-the-counter drug products that are formulated and marketed pursuant to the FDA’s governing regulations set forth at 21 CFR Part 333 Subpart D.